Novonesis (Novozymes) B (NSISBC.XD)
DKK 410.0
(-0.89%)
DKK 410.0
(-0.89%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 17.89 Billion DKK | 1.97% |
| 2022 | 17.55 Billion DKK | 17.4% |
| 2021 | 14.95 Billion DKK | 6.7% |
| 2020 | 14.01 Billion DKK | -2.52% |
| 2019 | 14.37 Billion DKK | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 6.83 Billion DKK | 48.42% |
| 2024 Q2 | 6.83 Billion DKK | -0.01% |
| 2023 Q2 | 4.21 Billion DKK | -8.78% |
| 2023 Q4 | 4.6 Billion DKK | 3.3% |
| 2023 Q1 | 4.62 Billion DKK | 2.08% |
| 2023 FY | 17.89 Billion DKK | 1.97% |
| 2023 Q3 | 4.45 Billion DKK | 5.67% |
| 2022 Q3 | 4.36 Billion DKK | 0.0% |
| 2022 FY | 17.55 Billion DKK | 17.4% |
| 2022 Q4 | 4.52 Billion DKK | 3.71% |
| 2021 FY | 14.95 Billion DKK | 6.7% |
| 2020 FY | 14.01 Billion DKK | -2.52% |
| 2019 FY | 14.37 Billion DKK | 0.0% |
| Name | Revenue | Revenue Difference |
|---|